Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
Public ClinicalTrials.gov record NCT03547973. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Open-Label Study of Sacituzumab Govitecan in Unresectable Locally Advanced/Metastatic Urothelial Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study is to evaluate the efficacy and safety of sacituzumab govitecan-hziy monotherapy and with novel combinations in participants with metastatic urothelial cancer (mUC).
Study identification
- NCT ID
- NCT03547973
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 502 participants
Conditions and interventions
Conditions
Interventions
- Sacituzumab Govitecan-hziy Drug
- Pembrolizumab Drug
- Cisplatin Drug
- Avelumab Drug
- Zimberelimab Drug
- Carboplatin Drug
- Gemcitabine Drug
- Domvanalimab Drug
- Enfortumab Vedotin Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 13, 2018 (Actual)
- Primary completion
- Apr 2030 (Estimated)
- Completion
- Apr 2030 (Estimated)
- Last update posted
- Sep 1, 2026
2018 – 2030
United States locations
- U.S. sites
- 30
- U.S. states
- 19
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The University of Arizona Cancer Center-North Campus | Tucson | Arizona | 85719 | — |
| University of California San Francisco | San Francisco | California | 94158 | — |
| Rocky Mountain Cancer Centers | Littleton | Colorado | 80120 | — |
| Smilow Cancer Hospital at Yale-New Haven | New Haven | Connecticut | 06510 | — |
| Mount Sinai Comprehensive Cancer Center | Miami Beach | Florida | 33140 | — |
| Woodlands Medical Specialists, PA | Pensacola | Florida | 32503 | — |
| Moffitt Cancer Center | Tampa | Florida | 33612 | — |
| Winship Cancer Institute, Emory University | Atlanta | Georgia | 30322 | — |
| University of Illinois Cancer Center | Chicago | Illinois | 60612 | — |
| University of Chicago Medical Center | Chicago | Illinois | 60637 | — |
| Southern Illinois University School of Medicine, Simmons Cancer Institute | Springfield | Illinois | 62702 | — |
| Norton Cancer Institute, Downtown | Louisville | Kentucky | 40202 | — |
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
| Karmanos Cancer Institute | Detroit | Michigan | 48201 | — |
| Precision Cancer Research / New Mexico Oncology & Hematology Consultants | Albuquerque | New Mexico | 87109 | — |
| Roswell Park Cancer Institute | Buffalo | New York | 14263 | — |
| Laura & Isaac Perlmutter Cancer Center at NYU Langone Health | New York | New York | 10016 | — |
| Drug Shipping Address: New York-Presbyterian Hospital | New York | New York | 10065 | — |
| Stony Brook Cancer Center | Stony Brook | New York | 11794 | — |
| St. Luke's Hosptial - Bethlehem Campus | Easton | Pennsylvania | 18045 | — |
| Medical University of Southern Carolina | Charleston | South Carolina | 29425 | — |
| Thompson Oncology Group - Knoxville West | Knoxville | Tennessee | 37932 | — |
| Henry-Joyce Cancer Clinic | Nashville | Tennessee | 37232 | — |
| Houston Methodist Hospital, Houston Methodist Cancer Center | Houston | Texas | 77030 | — |
| Mays Cancer Center | San Antonio | Texas | 78229 | — |
| University of Utah - Huntsman Cancer Hospital (IP Shipping Address) | Salt Lake City | Utah | 84112 | — |
| Virginia Oncology Associates | Hampton | Virginia | 23666 | — |
| Oncology Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care | Roanoke | Virginia | 24014 | — |
| Seattle Cancer Care Alliance | Seattle | Washington | 98109 | — |
| University of Wisconsin Clinical Science Center | Madison | Wisconsin | 53705 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 98 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03547973, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 1, 2026 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03547973 live on ClinicalTrials.gov.